-
Adocia S.A.S., Lyon, France Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic Late last year, Adocia partnered with Eli Lilly to develop and commercialize a version of Lilly's Humalog …
Published on 1/30/2012
-
Allenex AB(SSE:ALNX), Stockholm, Sweden Xenella Holding AB, Malmo, Sweden Business: Transplant Transplant company Allenex said Xenella (formerly Godcup 7154 AB) acquired 11.2 million shares (9.3%) at SEK1.50 per share, …
Published on 1/30/2012
-
Almirall S.A. (Madrid:ALM), Barcelona, Spain Galapagos N.V. (Euronext:GLPG; Pink:GLPYY), Mechelen, Belgium Business: Pulmonary Almirall and Galapagos' BioFocus subsidiary partnered to discover and develop drugs against …
Published on 1/30/2012
-
Alseres Pharmaceuticals Inc. (Pink:ALSE), Hopkinton, Mass. Navidea Biopharmaceuticals Inc. (NYSE-A:NAVB), Dublin, Ohio Business: Diagnostic Alseres granted Navidea an option to license exclusive, worldwide rights to …
Published on 1/30/2012
-
Amarantus BioSciences Inc. (OTCBB:AMBS), Sunnyvale, Calif. Power3 Medical Products Inc. (OTCBB:PWRM), The Woodlands, Texas Business: Diagnostic Power3 granted Amarantus a one-year, exclusive, worldwide license to …
Published on 1/30/2012
-
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Micromet Inc. (NASDAQ:MITI), Bethesda, Md. Business: Cancer Amgen will acquire Micromet for $11 per share in cash, or about $1.2 billion. The price is a 33% premium to …
Published on 1/30/2012
-
Appistry Inc., St. Louis, Mo. University of Missouri, Columbia, Mo. Business: Genomics Appistry granted the university a non-exclusive, worldwide license to Appistry's Ayrris/BIO software technology for genome …
Published on 1/30/2012
-
Arctic Partners Ab Oy, Turku, Finland Opko Health Inc. (NYSE:OPK), Miami, Fla. Business: Diagnostic Opko acquired exclusive rights to two kallikrein family biomarkers from Arctic Partners. Opko said it will develop a …
Published on 1/30/2012
-
AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Karolinska Institute, Stockholm, Sweden Business: Diagnostic, Neurology AstraZeneca and the institute partnered to develop diagnostic imaging tools to aid in developing …
Published on 1/30/2012
-
Avila Therapeutics Inc., Bedford, Mass. Celgene Corp. (NASDAQ:CELG), Summit, N.J. Business: Cancer Celgene will acquire Avila for $350 million in cash, plus up to $575 million in milestones. The milestones comprise up …
Published on 1/30/2012
-
Avila Therapeutics Inc., Bedford, Mass. Clovis Oncology Inc. (NASDAQ:CLVS), Boulder, Colo. Business: Cancer Avila received a $4 million milestone payment from Clovis under a 2010 deal granting Clovis an exclusive, …
Published on 1/30/2012
-
BioLineRx Ltd. (Tel Aviv:BLRX; NASDAQ:BLRX), Jerusalem, Israel Genoscience, Marseille, France Business: Infectious Genoscience granted BioLineRx exclusive, worldwide rights to preclinical oral HCV compound BL-8020. …
Published on 1/30/2012
-
BioMetrx LLC, Bethesda, Md. Georgetown University, Washington, D.C. Business: Cancer Georgetown University Medical Center granted newco BioMetrx exclusive, worldwide rights to cancer product Rasstore. Rasstore is a …
Published on 1/30/2012
-
BioTime Inc. (NYSE-A:BTX), Alameda, Calif. The Wistar Institute, Philadelphia, Pa. Business: Cancer The institute granted BioTime exclusive, worldwide rights to technology related to the SP100 gene. According to BioTime…
Published on 1/30/2012
-
Boulder Diagnostics Inc., Boulder, Colo. Portland State University, Portland, Ore. Business: Diagnostic Boulder Diagnostics and the university partnered to develop rapid diagnostic tests for homocysteine and related …
Published on 1/30/2012
-
Castle Biosciences Inc., Houston, Texas Indiana University Research and Technology Corp., Indianapolis, Ind. Business: Diagnostic Castle received exclusive, worldwide rights from the not-for-profit to IP related to the …
Published on 1/30/2012
-
Cooperative Diagnostics LLC, Greenwood, S.C. Lab21 Ltd., Cambridge, U.K. Business: Diagnostic Lab21 received a worldwide license to Cooperative's suite of patents for the development of molecular diagnostic kits. …
Published on 1/30/2012
-
General Electric Co. (NYSE:GE), Fairfield, Conn. Singapore Agency for Science, Technology and Research (A*STAR), Singapore Business: Diagnostic General Electric's GE Global Research technology development unit signed a …
Published on 1/30/2012
-
Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530; Osaka:4530), Tosu, Japan Yutoku Pharmaceutical lnd. Co. Ltd., Kashima City, Japan Business: Neurology Hisamitsu acquired a 15% stake in Yutoku Pharmaceutical through the …
Published on 1/30/2012
-
Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Microarrays, Genomics, Supply/Service Roche began an unsolicited tender offer to acquire sequencing and …
Published on 1/30/2012
-
IMS Health, Danbury, Conn. PharmARC Analytic Solutions Pvt. Ltd., Bangalore, India Business: Supply/Service IMS Health acquired commercial analytics company PharmARC. IMS said it gains complementary service offerings, …
Published on 1/30/2012
-
Ipsen Group (Euronext:IPN), Boulogne-Billancourt, France Santhera Pharmaceuticals Holding AG (SIX:SANN), Liestal, Switzerland Business: Neurology Ipsen returned exclusive rights outside North America and Japan to …
Published on 1/30/2012
-
Jubilant Life Sciences Ltd. (BSE:530019; NSE:JUBILANT), Noida, India Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Pharmaceuticals The companies mutually ended their Indian JV, Vanthys, which was formed in …
Published on 1/30/2012
-
La Jolla Pharmaceutical Co. (Pink:LBJC), San Diego, Calif. Solana Therapeutics Inc., La Jolla, Calif. Business: Cancer Solana reverse-merged with La Jolla. The new entity, which retains the name La Jolla, will focus on …
Published on 1/30/2012
-
Labcyte Inc., Sunnyvale, Calif. Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Business: Supply/Service Qiagen and Labcyte partnered to provide Qiagen's FlexiPlate siRNA reagent libraries in Labcyte's Echo…
Published on 1/30/2012